Experimental drug kills fat cells rather than shrinking them in small trials

· Science

An experimental drug killed fat cells instead of merely shrinking them, according to two small trials whose participants lost dangerous fat around their internal organs. That visceral fat is linked to health problems including diabetes and heart disease, making it a long-standing target for obesity and metabolic research. Most existing approaches reduce the size of fat cells rather than eliminating them, so a treatment that destroys the cells represents a different mechanism. The results come from two small trials, a preliminary stage that typically requires larger studies to confirm both efficacy and safety before any regulatory review.

Why it matters：A mechanism that removes visceral fat cells rather than shrinking them could open a distinct class of metabolic drugs, but small early trials frequently fail to replicate at scale.

Key points

  • Participants in two small trials lost dangerous fat around their internal organs
  • Visceral fat is linked to diabetes and heart problems
  • The drug kills fat cells rather than shrinking them

Sources (original reporting)

More stories from this day